M&D Supplements LLC – Trademark Portfolio

Entity Type: 16

M&D Supplements LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include M., MIDA, and MIDA HEALTH. The owner is based in St. Petersburg, FL.

7901 4th St N STE 300

St. Petersburg, FL 33702

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

M.
M.
Registered 2024
MIDA
MIDA
Registered 2024

Trademark Classifications

M&D Supplements LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does M&D Supplements LLC have?

M&D Supplements LLC has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does M&D Supplements LLC file in?

M&D Supplements LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.

What are M&D Supplements LLC's most well-known trademarks?

M&D Supplements LLC's registered trademark portfolio includes well-known marks such as M., MIDA, and MIDA HEALTH. These are among 3 currently registered trademarks in the portfolio.

What is M&D Supplements LLC's trademark registration success rate?

M&D Supplements LLC has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.